Sažetak sa skupa
ASSESMENT OF NUTRITIONAL STATUS OF PATINETS THAT BEGAN SYSTEMIC THERAPY OF COLORECTAL CANCER AT THE UNIVERSITY HOSPITAL FOR TUMORS
Maja Kovač
; Zavod za radioterapiju i internističku onkologiju Klinike za tumore, KBC Sestre milosrdnice Zagreb
Petra Lepetić
; Zavod za radioterapiju i internističku onkologiju Klinike za tumore, KBC Sestre milosrdnice Zagreb
Robert Šeparović
; Zavod za radioterapiju i internističku onkologiju Klinike za tumore, KBC Sestre milosrdnice Zagreb
Sažetak
Introduction: Obesity, measured by body mass index (BMI) of 30 kg/m2 or more, is etablished risk factor for the development of colorectal cancer. Unintetional body weight loss is one of the symptoms of colorectal cancer and unrecognised may lead to cachexia, associated with a poor outcomes of systemic antineoplastic therapy and patients poor quality of life.
Aim: The aim of this paper is to evaluate nutritional status of patients that began systemic therapy of colorectal cancer at the Department of Oncology, University Hospital for Tumors using the nutritional screening tool NRS 2002.
Methods: Retrospectivley we analysed nutritional status of 175 patients that began systemic therapy of colorectal cancer from May 2016 until May 2018. Low nutritional risk was defined as NRS 2002 score of 0-2 and high nutritional risk as NRS 2002 score of 3 or more. There were 106 men and 71 women, median age of 62 years.
Results: Majority of patients that began systemic therapy of colorectal cancer in analyzed period had low nutritional risk, 122 (70%) patients. High nutritional risk was observed in 53 (30%) patients, in 11 (37%) patients with early colorectal cancer and 42 (29%) patients with metastatic colorectal cancer. Majority of patients were overweight (BMI > 25 kg/m2) and in ¼ of these patients (27 (26%) patients) high nutritional risk was observed.
Conclusion: Assesment of nutritional status of colorectal cancer patients using appropriate nutritional screening tool should be implement in medical practice in order to provide adequate supportive care and therefore improve therapeutic and survival outcomes of colorectal cancer patients.
Ključne riječi
Hrčak ID:
218610
URI
Datum izdavanja:
31.12.2018.
Posjeta: 1.313 *